Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report.

Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM Jr, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV.

J Clin Psychiatry. 2010 Aug;71(8):1040-6. doi: 10.4088/JCP.10cs06070ablu. Epub 2010 Jul 13.

PMID:
20673551
2.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
3.

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G.

BMJ. 2009 Aug 11;339:b2880. doi: 10.1136/bmj.b2880. Review.

4.
6.

Assessing the role of drugs in suicidal ideation and suicidality.

Reith DM, Edmonds L.

CNS Drugs. 2007;21(6):463-72. Review.

PMID:
17521226
7.

Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.

Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004851. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD004851.

PMID:
17636776
8.

[SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].

Tandt H, Audenaert K, van Heeringen C.

Tijdschr Psychiatr. 2009;51(6):387-93. Review. Dutch.

9.

Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder.

Tauscher-Wisniewski S, Disch D, Plewes J, Ball S, Beasley CM.

Psychol Med. 2007 Nov;37(11):1585-93. Epub 2007 Jul 20. Review.

PMID:
17640442
11.
12.

Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.

Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2006 Dec;256(8):476-96. Epub 2006 Dec 1. Review.

PMID:
17143567
13.

Risk of adverse behavioral effects with pediatric use of antidepressants.

Goodman WK, Murphy TK, Storch EA.

Psychopharmacology (Berl). 2007 Mar;191(1):87-96. Epub 2006 Dec 19. Review.

PMID:
17180618
14.

Antidepressants and suicide: risk-benefit conundrums.

Healy D, Whitaker C.

J Psychiatry Neurosci. 2003 Sep;28(5):331-7. Review.

15.

Home treatment for mental health problems: a systematic review.

Burns T, Knapp M, Catty J, Healey A, Henderson J, Watt H, Wright C.

Health Technol Assess. 2001;5(15):1-139. Review.

16.

The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies.

Gelenberg AJ, Thase ME, Meyer RE, Goodwin FK, Katz MM, Kraemer HC, Potter WZ, Shelton RC, Fava M, Khan A, Trivedi MH, Ninan PT, Mann JJ, Bergeson S, Endicott J, Kocsis JH, Leon AC, Manji HK, Rosenbaum JF.

J Clin Psychiatry. 2008 Oct;69(10):1513-28. Epub 2008 Oct 7. Erratum in: J Clin Psychiatry. 2008 Dec;69(12):1985.

PMID:
19192434
17.

Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story.

Kutcher S, Gardner DM.

Curr Opin Psychiatry. 2008 Jan;21(1):65-9. doi: 10.1097/YCO.0b013e3282f29853. Review.

PMID:
18281842
18.

Child and adolescent suicide: epidemiology, risk factors, and approaches to prevention.

Pelkonen M, Marttunen M.

Paediatr Drugs. 2003;5(4):243-65. Review.

PMID:
12662120
19.

Confronting depression and suicide in physicians: a consensus statement.

Center C, Davis M, Detre T, Ford DE, Hansbrough W, Hendin H, Laszlo J, Litts DA, Mann J, Mansky PA, Michels R, Miles SH, Proujansky R, Reynolds CF 3rd, Silverman MM.

JAMA. 2003 Jun 18;289(23):3161-6. Review.

PMID:
12813122
20.

The measurement and monitoring of surgical adverse events.

Bruce J, Russell EM, Mollison J, Krukowski ZH.

Health Technol Assess. 2001;5(22):1-194. Review.

Items per page

Supplemental Content

Write to the Help Desk